Abiopharma

🔍 NightDragon Growth II, L.P. (Executive)

Company: HawkEye 360, Inc. (HAWK)

Report Date: 2026-05-07

Detailed Transactions and Holdings:

• Acquired 2,114,806 shares of COMMON STOCK (Direct)
  Date: 2026-05-08 | Code: C | equity_swap_involved: 0 | shares_owned_after: 2,114,806.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 271,102 shares of SERIES A-1 PREFERRED STOCK (Derivative)
  Date: 2026-05-08 | Code: C | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F2
• Sold 299,917 shares of SERIES A-2 PREFERRED STOCK (Derivative)
  Date: 2026-05-08 | Code: C | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F2
• Sold 101,477 shares of SERIES A-3 PREFERRED STOCK (Derivative)
  Date: 2026-05-08 | Code: C | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F2
• Sold 263,398 shares of SERIES B PREFERRED STOCK (Derivative)
  Date: 2026-05-08 | Code: C | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F2
• Sold 84,751 shares of SERIES C PREFERRED STOCK (Derivative)
  Date: 2026-05-08 | Code: C | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F2
• Sold 33,909 shares of SERIES D PREFERRED STOCK (Derivative)
  Date: 2026-05-08 | Code: C | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F2
• Sold 1,060,252 shares of SERIES E PREFERRED STOCK (Derivative)
  Date: 2026-05-08 | Code: C | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F2

Footnotes:

• F1: The Series A-1 Preferred Stock, Series A-2 Preferred Stock, Series A-3 Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, and Series E Preferred Stockautomatically converted into common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-1 basis, and had no expiration date.
• F2: The shares are held of record by NightDragon Growth II, L.P. ("NightDragon II"). NightDragon Growth GP II, LLC ("NightDragon GP II") is the general partner of NightDragon II. The Reporting Personis the managing member of NightDragon GP II and may be deemed to hold voting and investment power with respect to the shares held by NightDragon II.